2002 Annual Report of the Korea Central Cancer Registry: Based on Registered Data from 139 Hospitals

Abstract

R esults: O f the total of 99,025 malignancies, 55,398 (55.9% ) cases were males and 43,627 (44.1% ) were fem ales. M ore than one third of cases were from the elderly (65 years old and more). The six leading primary cancer sites in the order of their relative frequency, were stomach (24.0% ), followed by the lung (16.0% ), the liver (15.4% ), the colorectum (11.6% ), the bladder (3.2% ), and the prostate (3.0% ) among males. In females, the breast (16.8% ) was the common cancer site, followed by the stomach (15.3% ), the colorectum (10.7% ), the thyroid gland (9.5% ), the cervix uteri (9.1% ), and the lung (6.6% ).C onclusion: W ith the continued increase in cancer cases especially prostate cancer among males and thyroid cancer among females, the total number of registered cancer cases in Korea continues to rapidly increase.

Expression of excision repair cross-complementation group 1 protein predicts poor outcome in advanced non-small cell lung cancer patients treated with platinum-based doublet chemotherapy

“…The most commonly administered chemotherapy regimen was gemcitabine/cisplatin (gemcitabine 1000 mg/m 2 Chemotherapy was repeated every 3 weeks. If a response or stable disease was achieved after 2 cycles of chemotherapy, 2-4 additional cycles were administered according to the discretion of the physicians.…”

“…Lung cancer is the most common malignancy in many countries, and has become the number one cause of cancer death in Korea, surpassing gastric cancer [1,2]. The majority of lung cancer patients have non-small cell type, which accounts for 80-85% of new cases [1].…”

Phase II study of docetaxel and irinotecan combination chemotherapy in metastatic gastric carcinoma

“…Despite its decreasing incidence over the past few decades, gastric cancer remains one of the major causes of cancer deaths worldwide (Jemal et al, 2004) and is the most prevalent malignancy in Korea, constituting 24% of all solid tumours in males and 15% in females (Shin et al, 2004). Systemic chemotherapy is often used in patients with locally advanced or metastatic gastric cancer (MGC), but results of most combination regimens have been unsatisfactory, with median survival times of 6 -9 months (Webb et al, 1997;Vanhoefer et al, 2000;Ohtsu et al, 2003).…”

Genetic and expression analysis of the KCNRG gene in hepatocellular carcinomas

“…In Korea, HCC accounts for approximately 12.2% of all malignancies, 16.4% in the male population and 6.5% in the female (Shin et al, 2004). Etiological studies have shown that an infection with the hepatitis B or C virus (HBV or HCV) and the ingestion of aflatoxin B1-contaminated food might be important risk factors for HCC (Chen et al, 1977).…”